Subthreshold Micropulse Laser: Technique and Indications

Subthreshold micropulse laser delivers laser energy in short repeated pulses that heat the retinal pigment epithelium without a visible burn.

Clinicians use it for diabetic macular edema, vein occlusion edema, and some chronic serous disease, mainly near the fovea.

Because it avoids scars, it appeals when conventional laser would risk central vision.

---

How Subthreshold Micropulse Laser Works

Conventional laser uses a continuous wave that creates a visible burn and a scar.

In micropulse mode, the laser fires many tiny pulses with rest periods between them.

The duty cycle is the fraction of time that the laser is on, and it is usually 5 to 15 percent.

Because the tissue cools between pulses, heat spreads little, and the photoreceptors and neurosensory retina suffer minimal damage.

Researchers think that the effect comes from stimulating RPE cells to release factors that lower edema.

The exact mechanism is still debated, so treat the explanation as a working model.

Settings for Subthreshold Micropulse Laser

Platforms include 577 nm yellow and 810 nm diode systems.

Many clinicians test a threshold on a nearby area of retina with a continuous wave, then use a fraction of that energy in micropulse mode.

Common spot sizes are 160 to 200 micrometers, with a confluent pattern across the edematous area.

Settings differ by device, so follow the manufacturer’s guidance and local protocols (see panretinal photocoagulation for conventional laser comparison).

Indications

• Diabetic macular edema with center involvement and good vision
• Macular edema after branch retinal vein occlusion
• Chronic central serous disease, as a selected option
• Persistent edema after anti-VEGF therapy, as an adjunct

Evidence for Subthreshold Micropulse Laser

A meta-analysis of randomized trials found that micropulse laser matched conventional laser for diabetic macular edema and caused less retinal damage.

However, it was usually less effective than anti-VEGF injections for vision gain.

Studies vary in laser settings and follow-up, so pooled results carry uncertainty (see diabetic macular edema).

Advantages and Limits

The main advantage is safety, since it creates no scars and lets clinicians treat close to the fovea.

Treatment can be repeated if edema returns.

Disadvantages include the lack of a visible endpoint, the need for careful device training, and variable results.

Evidence for thick edema is weaker than for mild or moderate edema.

Safety Considerations

Complications are rare, though some eyes show faint pigment changes at high energy levels.

Check that the power stays low enough to avoid visible burns, and stop if a spot turns white.

Also use a contact lens with known magnification and keep the spot size consistent.

Practical Points

• Choose eyes with modest thickness and good vision
• Use OCT to follow the response at three months
• Combine with anti-VEGF drugs when edema is severe
• Explain that the benefit may appear slowly over weeks

An Example Case

A 62-year-old man with type 2 diabetes has center-involving macular edema with a central thickness of 380 micrometers and vision of 20/30.

He wants to avoid repeated injections because of travel limits.

After a discussion, he receives subthreshold micropulse laser across the thickened macula.

OCT at three months shows a small drop in thickness and stable vision.

He receives a second session at six months, and the macula stays stable for a year.

Subthreshold Micropulse Laser Versus Injections

Anti-VEGF drugs improve vision more often and work faster.

Micropulse laser avoids repeated injections, although it works more slowly and less strongly.

Therefore, many clinicians use it for mild edema, for patients who cannot attend often, or as an adjunct (see diabetic macular edema).

Pitfalls to Avoid

• Combine micropulse laser with injections in severe edema with poor vision
• Expect a slow response, which may take months
• Test the settings in a neutral area first
• Wait for the response before repeating treatment

Questions Patients Ask

Patients ask whether the laser hurts, and most feel little or nothing.

They also ask why they cannot see the treatment marks, and the answer is that the laser leaves no visible scars.

Explain that results vary and that injections may still be needed.

Also tell them that two or three sessions are common.

Key Points

Micropulse laser treats the retina without visible burns, so it suits eyes near the fovea.

Evidence shows safety and similarity to conventional laser, but weaker effects than anti-VEGF drugs.

Choose eyes with mild edema and good vision.

For the latest studies, see the PubMed results for subthreshold micropulse laser.

---

References

1. Chen G, Tzekov R, Li W, et al. Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials. Retina. 2016;36:2059-2065.
2. Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev. 2012;8:274-284.
3. Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern. Ophthalmology. 2020;127:P66-P145.
4. American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous. AAO; current edition.